期刊文献+

人黑色素肿瘤相关抗原gp100质粒诱导特异性抗小鼠黑色素瘤的免疫保护效应 被引量:2

Human gp100 induces specific anti-murine melanoma immune response, implicating a potential way to antitumor immunotherapy
原文传递
导出
摘要 目的以人黑色素肿瘤相关抗原hgp100基因免疫小鼠,诱导针对小鼠黑色素瘤的特异性免疫应答及保护效应。方法分别构建含全长人gp100(hgp100)和小鼠印100(mgp100)编码基因的质粒pcDNA3-hgp100和pcDNA3-mgp100,以100μg DNA肌肉免疫C57BL/6小鼠3次,每次间隔2周。通过体外免疫功能及体内攻击实验评价hgp100诱导对小鼠黑色素瘤的特异性免疫应答及保护效应。结果与mgp100比较,hgp100能诱导特异性针对mgp100的抗体生成和T细胞增殖及杀伤,产生以 IFN-γ分泌为主的特异性免疫应答;hgp100免疫小鼠在小鼠黑色素肿瘤细胞攻击后生存时间显著延长。结论人黑色素瘤相关抗原gp100可诱导特异性抗小鼠黑色素瘤的免疫应答及保护效应。 Objective To investigate the efficacy of hgp100, a human melanoma associate antigen, in inducing specific anfi-murine melanoma immune response and in protection via hgp100 plasmid. Methods Plasmids pcDNA3-hgp100 and pcDNA3-mgp100 were constructed by using full-length hgp100 and mgp100 coding sequence inserted into pcDNA3 vectors respectively. C57BL/6 mice were immunized intramuscularly with pcDNA3, pcDNA3-mgp100 and pcDNA3-hgp100 three times at two week intervals, separately. Specific anti-tumor antibody derived from immunized serum was detected kinetically by ELISA. Specific proliferation and cytotoxicity against B16F10 were detected. IFN-γ and IL-4 cytokines were measured. Mice immunized with plasmida were finally challenged with B16F10 melanoma tumor to observe the functional protection. Results Mice immunized with pcDNA3-hgp100 exhibited a significant protection (survival as long as 68 days) as compared to the mice immunized with pcDNA3-mgp100 only (survival to 29 days). Both T cell proliferation and cytotoxicity against murine melanoma were enhanced by hgp100 DNA immunization. An increased IFN-γ release and antibody production could also be detected after immunization with the pcDNA3-hgp100. Conclusion The data strongly indicated that anti-tumor immune response and protection against murine melanoma could be induced by human gp100, implicating a potential approach in anti-tumor immunotherapy.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2006年第4期334-338,共5页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金资助项目(30571713)上海市科委基金(045407038 04ZR14012)
关键词 pcDNA3-hgp100 pcDNA3-mgp100 小鼠黑色素瘤B16F10 pcDNA3-hgp100 pcDNA3-mgp100 Murine melanoma B16F10
  • 相关文献

参考文献10

  • 1Rosenberg SA.Cancer vaccines based on the identification of genes encoding cancer regression antigens.Immunol Today,1997,18:175-182.
  • 2Zhai Y,Yang JC,Spiess P,et al.Cloning and characterization of the genes encoding the mmrine homologues of the melanoma antigens MART1 and gp100.J Immunother,1997,20:15-25.
  • 3LecoeurH,FevrierM,GarciaS,etal.A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity.J Immunol Methods,2001,253:177-187.
  • 4Hartmann TB,Bazhin AV,Schadendorf D,et al.SEREX identification of new tumor antigens linked to melanoma-associated retinopathy.Int J Cancer,2005,114(1):88-93.
  • 5Benlalam H,Linard B,Guilloux Y,et al.Identification of five new HLA-B * 3501-restricted epitopes derived from common melanoma-associated antigens,spontaneously recognized by tumor-infiltrating lymphocytes.J Immunol,2003,171(11):6283-6289.
  • 6Wei YQ.Immunotherapy of tumors with vaccines based on xenogeneic homologous molecules.Anticancer Drugs,2002,13 (3):229-235.
  • 7Gallo P,Dharmapuri S,Nuzzo M,et al.Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector.Int J Cancer,2005,113(1):67-77.
  • 8Wei YQ,WangQR,ZhaoX,etal.Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine.Nat Med,2000,6:1160-1166.
  • 9Overwijk WW,Tsung A,Irvine KR,et al.gp100/pmel 17 is a murine umor rejection antigen:induction of "self"-reactive,tumoricidal T cells using high-affinity,altered peptide ligand.J Exp Med,1998,188:277-286.
  • 10Disis ML.Immunologic targets for breast cancer.Breast Dis,2002,15:83-90.

同被引文献43

  • 1刘杰,王清明,张云林,陈惠鹏.肽疫苗的研究进展[J].生物技术通讯,2004,15(4):405-408. 被引量:3
  • 2韩睿,程浩,朱可建.恶性黑素瘤血清学预后标记研究进展[J].实用肿瘤杂志,2007,22(4):371-373. 被引量:1
  • 3Thompson JF,Scolyer RA,Kefford RF.Cutaneous melanoma[J].The Lancet,2005,365 (9460):687-701.
  • 4Loftus SK,Antonellis A,Matera I,et al.Gpnmb is a melanoblastexpressed,MITF-dependent gene[J].Pigment cell & melanoma research,2009,22(1):99-110.
  • 5Deichmann M,Benner A,Bock M,et al.S100-Beta,melanoma-inhibiting activity,and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage Ⅳ melanoma[J].Journal of clinical oncology,1999,17(6):1891-1891.
  • 6Berson JF,Harper DC,Tenza D,et al.Pmel17 initiates premelanosome morphogenesis within multivesicular bodies[J].Molecular biology of the cell,2001,12(11):3451-3464.
  • 7Rosenberg SA.Cancer vaccines based on the identification of genes encoding cancer regression antigens[J].Immunology today,1997,18(4):175-182.
  • 8Tomihari M,Hwang SH,Chung JS,et al.Gpnmb is a melanosomeassociated glycoprotein that contributes to melanocyte/keratinocyte adhesion in a RGD-dependent fashion[.J].Exp Dermatol,2009,18(7):586-595.
  • 9Schwartzentruber DJ,Lawson DH,Richards JM,et al.GP100 peptide vaccine and interleukin-2 in patients with advanced melanoma[J].N Engl J Med,2011,364(22):2119-2127.
  • 10Rosenberg SA,Yang JC,Sherry RM,et al.Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen[J].Human gene therapy,2003,14(8):709-714.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部